Yunong Gao

2.8k total citations · 1 hit paper
55 papers, 1.4k citations indexed

About

Yunong Gao is a scholar working on Reproductive Medicine, Oncology and Surgery. According to data from OpenAlex, Yunong Gao has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Reproductive Medicine, 22 papers in Oncology and 17 papers in Surgery. Recurrent topics in Yunong Gao's work include Ovarian cancer diagnosis and treatment (24 papers), PARP inhibition in cancer therapy (12 papers) and Endometrial and Cervical Cancer Treatments (12 papers). Yunong Gao is often cited by papers focused on Ovarian cancer diagnosis and treatment (24 papers), PARP inhibition in cancer therapy (12 papers) and Endometrial and Cervical Cancer Treatments (12 papers). Yunong Gao collaborates with scholars based in China, Ethiopia and United Kingdom. Yunong Gao's co-authors include Weijiao Gao, Shishang Qin, Hanqiang Ouyang, Bin Zhang, Peng Du, Ranran Gao, Xianwen Ren, Sijin Cheng, Xiliang Wang and Xueda Hu and has published in prestigious journals such as Cell, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Yunong Gao

54 papers receiving 1.4k citations

Hit Papers

A pan-cancer single-cell ... 2021 2026 2022 2024 2021 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yunong Gao 555 552 510 235 210 55 1.4k
Takashi Miyatake 306 0.6× 179 0.3× 213 0.4× 281 1.2× 188 0.9× 47 1.0k
Amal Kanbour‐Shakir 224 0.4× 156 0.3× 189 0.4× 214 0.9× 288 1.4× 55 1.2k
Katsumi Tsukazaki 452 0.8× 174 0.3× 245 0.5× 326 1.4× 161 0.8× 65 1.1k
Mehran Ghaderi 319 0.6× 471 0.9× 219 0.4× 179 0.8× 159 0.8× 57 1.4k
Nader Husseinzadeh 270 0.5× 278 0.5× 296 0.6× 292 1.2× 256 1.2× 48 1.2k
Miriam Mints 285 0.5× 121 0.2× 124 0.2× 324 1.4× 193 0.9× 52 967
Mu‐Hsien Yu 813 1.5× 85 0.2× 236 0.5× 298 1.3× 186 0.9× 43 1.4k
Ting-Chang Chang 405 0.7× 91 0.2× 316 0.6× 478 2.0× 406 1.9× 30 1.4k
Rhona J. McVey 350 0.6× 144 0.3× 220 0.4× 198 0.8× 135 0.6× 32 991
Mark Messing 261 0.5× 87 0.2× 420 0.8× 121 0.5× 225 1.1× 31 1.1k

Countries citing papers authored by Yunong Gao

Since Specialization
Citations

This map shows the geographic impact of Yunong Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunong Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunong Gao more than expected).

Fields of papers citing papers by Yunong Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunong Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunong Gao. The network helps show where Yunong Gao may publish in the future.

Co-authorship network of co-authors of Yunong Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Yunong Gao. A scholar is included among the top collaborators of Yunong Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunong Gao. Yunong Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Qinglei, Xingyu Liu, Bairong Xia, et al.. (2024). Efficacy of sintilimab plus bevacizumab in recurrent/persistent ovarian clear cell carcinoma (INOVA): A multicenter, single-arm, phase II trial. Gynecologic Oncology. 190. S37–S37. 1 indexed citations
3.
Wang, Wei, Xiao-Ting Li, Yunong Gao, Hong Zheng, & Min Gao. (2023). A nomogram prediction model for the TP53mut subtype in endometrial cancer based on preoperative noninvasive parameters. BMC Cancer. 23(1). 720–720. 2 indexed citations
5.
Zhang, Nan, et al.. (2023). Real-world study of bevacizumab treatment in patients with ovarian cancer: a Chinese single-institution study of 155 patients. BMC Women s Health. 23(1). 178–178. 5 indexed citations
6.
Xia, Lingfang, Qi Zhou, Yunong Gao, et al.. (2022). A multicenter phase 2 trial of camrelizumab plus famitinib for women with recurrent or metastatic cervical squamous cell carcinoma. Nature Communications. 13(1). 7581–7581. 17 indexed citations
7.
Gao, Yunong, et al.. (2022). Comments on National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version). Chinese Journal of Cancer Research. 34(5). 458–459. 1 indexed citations
8.
Shu, Tong, Zhipeng Zhou, Jing Bai, et al.. (2022). Circulating T-cell receptor diversity as predictive biomarker for PARP inhibitors maintenance therapy in high grade serous ovarian cancer. Gynecologic Oncology. 168. 135–143. 1 indexed citations
9.
Cheng, Sijin, Ziyi Li, Ranran Gao, et al.. (2021). A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 184(3). 792–809.e23. 820 indexed citations breakdown →
10.
Wang, Sha, Hongwu Wen, Yunong Gao, et al.. (2021). Assessment of Pelvic Floor Function and Quality of Life in Patients Treated for Cervical Cancer: A Multicenter Retrospective Study. Gynecologic and Obstetric Investigation. 86(4). 353–360. 11 indexed citations
11.
Zheng, Hong, Tong Shu, Shan Zhu, et al.. (2021). Construction and Validation of a Platinum Sensitivity Predictive Model With Multiple Genomic Variations for Epithelial Ovarian Cancer. Frontiers in Oncology. 11. 725264–725264. 9 indexed citations
12.
Wu, Xiaotong, Lingying Wu, Yumei Wu, et al.. (2021). Evaluation of the sexual quality of life and sexual function of cervical cancer survivors after cancer treatment: a retrospective trial. Archives of Gynecology and Obstetrics. 304(4). 999–1006. 25 indexed citations
13.
Wang, Shiyan, Lei Gao, Hongwu Wen, et al.. (2021). Evaluation of pelvic floor muscle function (PFMF) in cervical cancer patients with Querleu–Morrow type C hysterectomy: a multicenter study. Archives of Gynecology and Obstetrics. 305(2). 397–406. 2 indexed citations
16.
Wu, Lingying, Jianqing Zhu, Rutie Yin, et al.. (2020). Olaparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer and a BRCA1 and/or BRCA2 mutation: SOLO1 China cohort. Gynecologic Oncology. 160(1). 175–181. 26 indexed citations
17.
Gao, Yunong, et al.. (2019). Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer. International Journal of Gynecological Cancer. 29(4). 761–767. 13 indexed citations
18.
Kim, Hoon-Kyo, Ruey-Kuen Hsieh, Alexandre Chan, et al.. (2014). Impact of CINV in earlier cycles on CINV and chemotherapy regimen modification in subsequent cycles in Asia Pacific clinical practice. Supportive Care in Cancer. 23(1). 293–300. 16 indexed citations
19.
Gao, Weijiao, et al.. (2013). Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional study. BMC Infectious Diseases. 13(1). 271–271. 141 indexed citations
20.
Cao, Kun, Min Gao, Ying‐Shi Sun, et al.. (2011). Apparent diffusion coefficient of diffusion weighted MRI in endometrial carcinoma—Relationship with local invasiveness. European Journal of Radiology. 81(8). 1926–1930. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026